Literature DB >> 17178968

Induction chemoradiation for rectal cancer.

Nancy Han1, Susan Galandiuk.   

Abstract

OBJECTIVE: To review the application, outcome, and recent developments of neoadjuvant chemoradiation therapy with respect to rectal cancer. DATA SOURCES AND STUDY SELECTION: Articles written in English after 1980 selected from MEDLINE and PubMed from the National Library of Medicine. Case reports were excluded. There were no other criteria for exclusion of published information pertaining to this topic. DATA EXTRACTION AND SYNTHESIS: Articles were obtained and organized from MEDLINE and PubMed as well as the reference lists of pertinent literature.
CONCLUSIONS: Published reports have demonstrated that neoadjuvant chemoradiation improves survival and decreases local recurrence in patients with stage II and III rectal cancers. It is anticipated that advances and technical developments in both chemotherapy and radiation therapy will lead to improved oncologic results with decreased toxic side effects.

Entities:  

Mesh:

Year:  2006        PMID: 17178968     DOI: 10.1001/archsurg.141.12.1246

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  7 in total

1.  Safety of laparoscopic total mesorectal excision for low rectal cancer with preoperative chemoradiation therapy.

Authors:  Takashi Akiyoshi; Hiroya Kuroyanagi; Masatoshi Oya; Tsuyoshi Konishi; Meiki Fukuda; Yoshiya Fujimoto; Masashi Ueno; Toshiharu Yamaguchi; Tetsuichiro Muto
Journal:  J Gastrointest Surg       Date:  2008-11-15       Impact factor: 3.452

2.  Short-term outcomes after laparoscopic surgery following preoperative chemoradiotherapy for rectal cancer.

Authors:  Byong Hyon Ahn; Kyung Ha Lee; Jun Beom Park; Min Sang Song; Ji Yeon Kim; Jin Soo Kim
Journal:  J Korean Surg Soc       Date:  2012-10-29

3.  Survivin expression can predict the effect of chemoradiotherapy for advanced lower rectal cancer.

Authors:  Chie Takasu; Mitsuo Shimada; Nobuhiro Kurita; Takashi Iwata; Hirohiko Sato; Masanori Nishioka; Shinya Morimoto; Kozo Yoshikawa; Tomohiko Miyatani; Hideya Kashihara; Tohru Utsunomiya; Hisanori Uehara
Journal:  Int J Clin Oncol       Date:  2012-08-31       Impact factor: 3.402

4.  Impact of neoadjuvant treatment on total mesorectal excision for ultra-low rectal cancers.

Authors:  Yon Kuei Lim; Wai Lun Law; Rico Liu; Jensen T C Poon; Joe F M Fan; Oswens S H Lo
Journal:  World J Surg Oncol       Date:  2010-03-26       Impact factor: 2.754

5.  Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing Neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot study.

Authors:  David W Dietz; Farrokh Dehdashti; Perry W Grigsby; Robert S Malyapa; Robert J Myerson; Joel Picus; Jon Ritter; Jason S Lewis; Michael J Welch; Barry A Siegel
Journal:  Dis Colon Rectum       Date:  2008-08-06       Impact factor: 4.585

6.  Surgical outcome of abdominoperineal resection for low rectal cancer in a Nigerian tertiary institution.

Authors:  Olusegun I Alatise; Oladejo O Lawal; Abdulrasheed K Adesunkanmi; Stephen A Osasan
Journal:  World J Surg       Date:  2009-02       Impact factor: 3.352

7.  Early Assessment of Colorectal Cancer by Quantifying Circulating Tumor Cells in Peripheral Blood: ECT2 in Diagnosis of Colorectal Cancer.

Authors:  Chih-Jung Chen; Wen-Wei Sung; Hung-Chang Chen; Yi-Jye Chern; Hui-Ting Hsu; Yueh-Min Lin; Shu-Hui Lin; Konan Peck; Kun-Tu Yeh
Journal:  Int J Mol Sci       Date:  2017-03-31       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.